Document is current
Any future updates will be listed below
-
Authors
Liu, Xinyue https://orcid.org/0000-0002-1187-493X
Rao, Siyuan https://orcid.org/0000-0002-1555-487X
Chen, Weixuan https://orcid.org/0009-0003-2374-6681
Felix, Kayla
Ni, Jiahua
Sahasrabudhe, Atharva
Lin, Shaoting
Wang, Qianbin
Liu, Yuanyuan
He, Zhigang https://orcid.org/0000-0001-6080-6880
Xu, Jingyi
Huang, Sizhe https://orcid.org/0009-0003-8923-8946
Hong, Eunji
Yau, Todd
Anikeeva, Polina https://orcid.org/0000-0001-6495-5197
Zhao, Xuanhe https://orcid.org/0000-0001-5387-6186
- License Information
-
More Information
Article History
Received: 28 March 2022
Accepted: 21 August 2023
First Online: 19 October 2023
Competing interests
: P.A. has a financial interest in NeuroBionics Inc., a biotechnology company focused on the development of multifunctional fibers for research and clinical applications. X.Z. has a financial interest in SanaHeal, a biotechnology company focused on the development of medical devices for surgical sealing and repair. Z.H. is an advisor for Myro Therapeutics, Axonis and Rugen Therapeutics. The remaining authors declare no competing interests.
